Results 191 to 200 of about 5,764,428 (380)

Rapid on-site universal vertebrate species identification via multi-barcode nanopore sequencing. [PDF]

PLoS One
Patterson EC, Morrison-Lanjouw S, Jobling MA, Wetton JH.   +3 more
europepmc   +1 more source

Protein-Protein Interaction Network Analysis and Identification of Key Players in nor-NOHA and NOHA Mediated Pathways for Treatment of Cancer through Arginase Inhibition: Insights from Systems Biology

, 2018
Ishtiaque Ahammad
openalex   +2 more sources

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Forage preference in two geographically co-occurring fungus gardening ants: A dietary DNA approach. [PDF]

PLoS One
Richards-Perhatch V M, Boshers E, Greenwold M, Seal JN.   +3 more
europepmc   +1 more source

Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks [PDF]

, 2009
Xuewen Song, Valeria Di Giovanni, Ning He, Kairong Wang, Alistair J. Ingram, Norman D. Rosenblum, York Pei   +6 more
openalex   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Chloroplast genome analysis and phylogenetic position of Polygonatum sinopubescens and comparison with related species. [PDF]

PLoS One
Mo ZM, Wei CM, Yu HY, Yang CD.
europepmc   +1 more source

Advances in bladder cancer biology and therapy

Nature Reviews. Cancer, 2020
Linda L Tran, Jin-Fen Xiao, N. Agarwal, Jason E. Duex, D. Theodorescu   +4 more
semanticscholar   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Special Issue "Molecular Biology of the Thyroid Cancer and Thyroid Dysfunctions". [PDF]

Int J Mol Sci
Vija L.
europepmc   +1 more source